Video
22 Aug 2022
Veranova products and service video
Introducing Veranova - a CDMO that manages complexity with confidence.
Content provided by our supplier
Veranova, L.P.
-
Country/Region:United States
-
On CPHI since:2022
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Other Content from Veranova, L.P. (6)
-
.png)
Video Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence
Antibody-drug conjugates (ADCs) are pioneering biologics that merge antibodies’ specificity with small molecules’ potency. With a handful of FDA-approved ADCs in the market and many under development, ADCs are poised to revolutionize therapeutics. This talk examines the complexities of ADC production, emphasizing the importance of process characterization and the pivotal role of supply chain characteristics, safety requirements, and Contract Manufacturing Organizations (CMOs) with proficiency. The swift transition of antibody-drug conjugate (ADC) programs from early to advanced clinical stages underscores the urgency for quick and efficient commercial launch preparation. We will delve into strategies to hasten commercial readiness, supply chain strategy, the significance of partnering with adept contract development and manufacturing organizations (CDMOs), and the challenges of ADC production. -
Brochure API and Controlled Substance Product Guide
List of Veranova's APIs and Controlled Substances -
Brochure Veranova Solid Form and Particle Engineering
A guide to Veranova's Solid Form and Particle Engineering services (under our Pharmorphix® brand). -
Brochure Veranova Solid Form and Particle Engineering
Veranova Pharmorphix ® products and services -
Brochure Veranova Solid Form and Particle Engineering
Pharmorphix® products and services -
Datasheet Veranova Solid Form and Particle Engineering
Phramorphix® solid form and particle engineering products and services